Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study

Stroke

Volumn 44, Issue 7, 2013, Pages 1803-1808

  Dadu, Razvan T ^a,b   Fornage, Myriam ^c   Virani, Salim S ^a,b,d   Nambi, Vijay ^a,b   Hoogeveen, Ron C ^a,b   Boerwinkle, Eric ^c   Alonso, Alvaro ^e   Gottesman, Rebecca F ^f   Mosley, Thomas H ^g   Ballantyne, Christie M ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

brain infarcts ? white matter lesions ? cardiovascular biomarkers ? MRI ? subclinical brain injur

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; BRAIN DISEASE; CHOLESTEROL BLOOD LEVEL; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; RISK FACTOR;

BRAIN INFARCTS; CARDIOVASCULAR BIOMARKERS; MRI; SUBCLINICAL BRAIN INJURY; WHITE MATTER LESIONS;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BRAIN INFARCTION; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; LEUKOENCEPHALOPATHIES; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RISK FACTORS; TROPONIN T;

EID: 84879994753     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.001128     Document Type: Article

References (37)

1. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, et al; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation. 2007;116:2634-2653
2. Januzzi JL, van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordonez- Llanos J, Santalo-Bel M, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J. 2006;27:330-337
3. Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R, Saleheen D, et al. B-type natriuretic peptides and cardiovascular risk: systematic review and meta-Analysis of 40 prospective studies. Circulation. 2009;120:2177-2187
4. Saunders JT, Nambi V, de Lemos JA, Chambless LE, Virani SS, Boerwinkle E, et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation. 2011;123:1367-1376
5. deFilippi CR, de Lemos JA, Christenson RH, Gottdiener JS, Kop WJ, Zhan M, et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA. 2010;304:2494-2502
6. Ostrow PT, Miller LL. Pathology of small artery disease. Adv Neurol. 1993;62:93-123
7. Gamble CN. The pathogenesis of hyaline arteriolosclerosis. Am J Pathol. 1986;122:410-420
8. Bezerra DC, Sharrett AR, Matsushita K, Gottesman RF, Shibata D, Mosley TH Jr, et al. Risk factors for lacune subtypes in the Atherosclerosis Risk in Communities (ARIC) Study. Neurology. 2012;78:102-108
9. Kim BJ, Lee SH, Kim CK, Ryu WS, Kwon HM, Choi SY, et al. Advanced coronary artery calcification and cerebral small vessel diseases in the healthy elderly. Circ J. 2011;75:451-456
10. Sonohara K, Kozaki K, Akishita M, Nagai K, Hasegawa H, Kuzuya M, et al. White matter lesions as a feature of cognitive impairment, low vitality and other symptoms of geriatric syndrome in the elderly. Geriatr Gerontol Int. 2008;8:93-100
11. Debette S, Beiser A, DeCarli C, Au R, Himali JJ, Kelly-Hayes M, et al. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke. 2010;41:600-606
12. Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Jolles J, Koudstaal PJ, et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain. 2005;128(pt 9):2034-2041
13. White AD, Folsom AR, Chambless LE, Sharret AR, Yang K, Conwill D, et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years experience. J Clin Epidemiol. 1996;49:223-233
14. Agarwal SK, Avery CL, Ballantyne CM, Catellier D, Nambi V, Saunders J, et al. Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study. Clin Chem. 2011;57:891-897
15. Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, et al. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population. Eur Heart J. 2007;28:1374-1381
16. Knopman DS, Mosley TH, Catellier DJ, Sharrett AR; Atherosclerosis Risk in Communities (ARIC) Study. Cardiovascular risk factors and cerebral atrophy in a middle-Aged cohort. Neurology. 2005;65:876-881
17. Manolio TA, Kronmal RA, Burke GL, Poirier V, OLeary DH, Gardin JM, et al. Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. Stroke. 1994;25:318-327
18. Longstreth WT Jr, Dulberg C, Manolio TA, Lewis MR, Beauchamp NJ Jr, OLeary D, et al. Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke. 2002;33:2376-2382
19. Longstreth WT Jr. Brain vascular disease overt and covert. Stroke. 2005;36:2062-2063
20. Irfan A, Twerenbold R, Reiter M, Reichlin T, Stelzig C, Freese M, et al. Determinants of high-sensitivity troponin T among patients with a noncardiac cause of chest pain. Am J Med. 2012;125:491-498
21. Srisawasdi P, Vanavanan S, Charoenpanichkit C, Kroll MH. The effect of renal dysfunction on BNP, NT-proBNP, and their ratio. Am J Clin Pathol. 2010;133:14-23
22. Kim BJ, Choi SY, Lee SH, Kim CK, Ryu WS, Han MK, et al. Advanced coronary artery calcification is associated with ischemic stroke. Cerebrovasc Dis. 2010;30:93-100
23. Iijima K, Akishita M, Ouchi Y. Coronary artery calcification and cerebral small vessel disease. Association of systemic atherosclerosis. Circ J. 2011;75:272-273
24. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004;350:655-663
25. Reinhard H, Garde E, Skimminge A, keson P, Ramsy TZ, Winther K, et al. Plasma NT-proBNP and white matter hyperintensities in type 2 diabetic patients. Cardiovasc Diabetol. 2012;11:119.
26. Taylor J, Stott DJ. Chronic heart failure and cognitive impairment: coexistence of conditions or true association? Eur J Heart Fail. 2002;4:7-9
27. Schwartzkopff B, Mundhenke M, Strauer BE. Remodelling of intramyocardial arterioles and extracellular matrix in patients with arterial hypertension and impaired coronary reserve. Eur Heart J. 1995;16(suppl I):82-86
28. Zheng J, Ye P, Luo L, Xiao W, Xu R, Wu H. Association between blood glucose levels and high-sensitivity cardiac troponin T in an overt cardiovascular disease-free community-based study. Diabetes Res Clin Pract. 2012;97:139-145
29. Jeremias A, Gibson CM. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med. 2005;142:786-791
30. Yang EY, Chambless L, Sharrett AR, Virani SS, Liu X, Tang Z, et al. Carotid arterial wall characteristics are associated with incident ischemic stroke but not coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2012;43:103-108
31. Choi SY, Park HE, Seo H, Kim M, Cho SH, Oh BH. Arterial stiffness using cardio-Ankle vascular index reflects cerebral small vessel disease in healthy young and middle aged subjects. J Atheroscler Thromb. 2013;20:178-185
32. Saji N, Kimura K, Shimizu H, Kita Y. Silent brain infarct is independently associated with arterial stiffness indicated by cardio-Ankle vascular index (CAVI). Hypertens Res. 2012;35:756-760
33. Marti CN, Gheorghiade M, Kalogeropoulos AP, Georgiopoulou VV, Quyyumi AA, Butler J. Endothelial dysfunction, arterial stiffness, and heart failure. J Am Coll Cardiol. 2012;60:1455-1469
34. Desai AS, Mitchell GF, Fang JC, Creager MA. Central aortic stiffness is increased in patients with heart failure and preserved ejection fraction. J Card Fail. 2009;15:658-664
35. Rutten JH, Mattace-Raso FU, Verwoert GC, Lindemans J, Hofman A, Witteman JC, et al. Arterial stiffness as determinant of increased amino terminal pro-B-type natriuretic peptide levels in individuals with and without cardiovascular disease-The Rotterdam Study. J Hypertens 2010;28:2061-2067
36. Nielsen LB, Bartels ED, Bollano E. Overexpression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice. J Biol Chem. 2002;277:27014-27020
37. Gumy LF, Bampton ET, Tolkovsky AM. Hyperglycaemia inhibits Schwann cell proliferation and migration and restricts regeneration of axons and Schwann cells from adult murine DRG. Mol Cell Neurosci. 2008;37:298-311.